Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Operating Leases (2019 - 2025)

Aethlon Medical filings provide 7 years of Operating Leases readings, the most recent being $336718.0 for Q1 2025.

  • On a quarterly basis, Operating Leases fell 48.18% to $336718.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $336718.0, a 48.18% decrease, with the full-year FY2025 number at $336718.0, down 48.18% from a year prior.
  • Operating Leases hit $336718.0 in Q1 2025 for Aethlon Medical, down from $417522.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.1 million in Q3 2022 to a low of $287221.0 in Q4 2021.
  • Median Operating Leases over the past 5 years was $626128.0 (2022), compared with a mean of $667953.9.
  • Biggest five-year swings in Operating Leases: surged 251.39% in 2022 and later crashed 48.18% in 2025.
  • Aethlon Medical's Operating Leases stood at $287221.0 in 2021, then surged by 251.39% to $1.0 million in 2022, then dropped by 28.18% to $724848.0 in 2023, then plummeted by 42.4% to $417522.0 in 2024, then decreased by 19.35% to $336718.0 in 2025.
  • The last three reported values for Operating Leases were $336718.0 (Q1 2025), $417522.0 (Q4 2024), and $496772.0 (Q3 2024) per Business Quant data.